Genmab | Zysk Brutto Na Sprzedaży



Gross Profit On Sales Zmiana Data
Agios Pharmaceuticals USD 7.64M 1.83M 2025-03
Almirall EUR 231.69M 73.09M 2024-06
Amarin USD 16.28M 26.49M 2024-09
Amgen USD 5.54B 430M 2025-03
argenx SE USD 665.76M 371.88M 2024-12
AstraZeneca USD 11.35B 819M 2025-03
Bayer EUR 6.01B 1.13B 2024-12
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Demant DKK 8.58B 4.32B 2024-12
Exelixis USD 546.79M 24.58M 2025-01
Fresenius Medical Care EUR 1.27B 124.43M 2024-12
Galapagos EUR 61.25M 98.68M 2025-03
Genmab DKK 6.1B 837M 2024-12
GlaxoSmithKline GBP 5.59B 34M 2025-03
GN Store Nord DKK 2.19B 482M 2025-03
GRIFOLS EUR 766.49M 39.74M 2024-12
Hikma Pharmaceutical USD 756M 82M 2024-06
Insmed USD 78.29M 6.04M 2024-12
Lonza CHF 1.12B 276M 2024-06
Merck EUR 3.1B 45M 2024-12
Novartis USD 10.23B 294M 2024-12
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.72B 2.36B 2025-03
UCB EUR 970M 788M 2024-06



Genmab Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.